Who is sponsoring NCT04945811?

NCT04945811 is sponsored by FARAH AFZAL.

What drugs are being tested in NCT04945811?

Interventions in NCT04945811: Interlukein 6 and procalcitonin serum levels.

What condition does NCT04945811 study?

NCT04945811 studies Covid19 Positive Patients.

Is NCT04945811 still recruiting?

NCT04945811 is currently completed. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04945811

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta

Completed NA Last updated 30 June 2021

What this trial tests

NA trial testing Interlukein 6 and procalcitonin serum levels in Covid19 Positive Patients in 100 participants. Completed in 30 May 2021.

Timeline

1 April 2020

Primary endpoint
15 May 2021

30 May 2021

Quick facts

Lead sponsor	FARAH AFZAL
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	100
Start date	1 April 2020
Primary completion	15 May 2021
Estimated completion	30 May 2021
Sites	1 location across Pakistan

Drugs / interventions tested

Interlukein 6 and procalcitonin serum levels

Conditions studied

Covid19 Positive Patients — all drugs for Covid19 Positive Patients →

Sponsor

FARAH AFZAL

Who can join

Adults 38 to 71, any sex, with Covid19 Positive Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Serum Interleukin-6 and Procalcitonin of 100 consenting COVID 19 positive patients from April 2020 - May 2021 were assessed at Pathology department CMH Quetta and the results were correlated with severity of lung involvement on HRCT Chest

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04945811 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FARAH AFZAL
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing